ClinicalTrials.gg
CompletedNCT01633021Updated Oct 29, 2026

Developing the Family Map: Looking at Communal Coping

An observational study in Sickle Cell, Diabetes and Cancer, sponsored by National Human Genome Research Institute (NHGRI). Completed at 3 sites in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by National Human Genome Research Institute (NHGRI) · Observational

Study type
Observational
Model
Family-based
Time perspective
Cross-sectional
Enrollment
1,061
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Background:

- Knowing one s family medical history is a part of staying healthy. Some health risks run in families, and knowing these risks can promote more healthy behavior. Different social and cultural factors may affect how family members share this information. Genetic risk information that is shared in one family may not be shared in the same way in another. This information may also be shared differently between spouses, siblings, or parents and children. It may even be shared with more distant relatives. Knowing the information that family members share and how they share it may help researchers improve genetic disease treatment and support plans. Family surveys of people who have genetic health risks may help provide this information.

Objectives:

- To study how family members affected by genetic-related diseases share health information with each other.

Eligibility:

  • Individuals at least 18 years of age who can read English or Spanish.
  • Participants affected by a genetic disease or be related or married to someone who has the disease.

Design:

  • Participants will be screened with an initial questionnaire. They will identify their genetic disease and provide a basic health history.
  • Participants who have the disease will complete an online survey or participate in a personal interview. The questions will take about 45 minutes to 1 hour to answer. The survey will ask about family health history and family support. Participants will also provide referrals to a spouse or relatives who will participate in the study.
  • The spouse or relative will answer a similar survey. The survey will ask about health history and support for the spouse/relative with the disease.
  • A gift card will be given as thanks for participating in the study.
Read the detailed description

Facilitating the dissemination of disease risk information and promoting engagement in healthful behaviors within families may be enhanced by using network-based interventions. Network-based interventions are innovative in that they are tailored to the structure of the social system within which individuals are embedded. Understanding the social and relational factors associated with processes of family risk dissemination, family encouragement, and support is essential to developing network-based intervention tools targeting the family. The first objective of the current project is to ascertain those key social pathways that can be used in a family-centered network-based intervention that promotes disease prevention and health promotion in at-risk families. To this end, efforts will be focused on assessing whether there is a consistent, small set of relational characteristics associated with the dissemination of family risk information and processes of both behavioral and emotional adaptation to disease risk across various disease and cultural contexts. The second objective is to examine the feasibility of using cognitive network approaches to assess social interactions among family members as a means to enhance the implementation of a network-based intervention. A cognitive network is an individual's perception of the relationships among their family (or network) members. Thus, cognitive network approaches can potentially be used to capture an accurate representation of family social structure based on the information provided by a small subset of optimally situated family members. Those key social pathways identified within the first objective of this research will be used to address the second objective. Families affected by diseases and disorders that span the spectrum of genetic penetrance, ranging from highly penetrant, monogenetic disease to less penetrant, common complex conditions, will be recruited for the study. Further, the current effort will seek to engage samples from diverse cultural backgrounds to address our limited knowledge regarding risk communication and adaptation in such families and to facilitate generalization of results. Study participants will be recruited from established cohorts, outreach events, or ongoing studies, both at the NIH and at extramural institutions. Family members will be recruited using a snowball sampling approach and will be asked to complete an in-person, web-based and/or telephone survey/interview. Interviews will have a semi-structured format to allow for slight deviations in prompts and probes to address participant questions. The research addressed in this protocol will lead to the development of an innovative methodology with the potential to improve the design and implementation of family-based interventions that promote disease prevention.

02

Conditions studied

  • Sickle Cell
  • Diabetes
  • Cancer
  • Cardiovascular Disease
  • Genetic Screening

Keywords

  • Support
  • Cancer
  • Network
  • Diabetes
  • Sickle Cell Trait / Sickle Cell Disease
  • Natural History
03

In context

Diabetes Mellitus

8,290 studies on the registry are indexed under Diabetes Mellitus; 1,077 are open to participants now.

This study's enrollment of 1,061 is above the median of 246 across 1,936 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

National Human Genome Research Institute (NHGRI) is the lead sponsor of 203 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Recruitment is appropriate to the disease/screening-specific context, and may work with advocacy groups. Prospective participants who have / are at risk for chronic genetic disease (or are related to someone affected by condition) may be eligible to participate.@@@

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older
  • Ability to complete in-person, web-based or telephone survey/interview(s)
  • Ability to read English or Spanish (in some cases)
  • Affected by or have at least one first- or second-degree relative affected by or have a spouse/partner affected by the disease(s) of interest OR Biological or non-biological (e.g. adopted, step, spouse, family through marriage) relative of the primary participant.

Exclusion criteria

EXCLUSION CRITERIA:

Individuals with cognitive difficulties will be excluded from the study, as participants will be required to comprehend and legally consent to participation in this study and complete the survey/interview(s).

05

Study design

Observational model
Family-based
Time perspective
Cross-sectional
Enrollment
1,061 participants (actual)

Groups and cohorts

  • Diabetes

    Self/Family member affected by type-2 diabetes (plus self-referred family-members)

  • Heritable Cancer Screen-Positive

    Person who has screened-positive for heritable cancers on genetic tests (plus referred family-members)

  • Sickle Cell (Trait/Disease/Related)

    Self/Family member affected by Sickle Cell Trait or Sickle Cell Disease (plus self-referred family-members)

06

What researchers measure

Primary outcomes

  1. Social & relational factors from family network data

    Identify social and relational factors used to characterize family environment re communication of health information, encouragement of health behaviors, provision of support.

    Time frame: Varies by sub-study

Secondary outcomes

  1. Cognitive network utility evaluation

    Evaluate the utility of cognitive network approaches to characterize the family social environment

    Time frame: Varies by sub-study

07

Study locations

3 sites
  • National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
    Bethesda, Maryland 20892, United States
  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039, United States
  • Geisinger Autism & Developmental Medicine Institute
    Lewisburg, Pennsylvania 17837, United States
08

References and documents

Publications

  • Lewis MA, McBride CM, Pollak KI, Puleo E, Butterfield RM, Emmons KM. Understanding health behavior change among couples: an interdependence and communal coping approach. Soc Sci Med. 2006 Mar;62(6):1369-80. doi: 10.1016/j.socscimed.2005.08.006. Epub 2005 Sep 16. PubMed 16146666 ↗
  • Stokols D. Establishing and maintaining healthy environments. Toward a social ecology of health promotion. Am Psychol. 1992 Jan;47(1):6-22. doi: 10.1037//0003-066x.47.1.6. PubMed 1539925 ↗
  • Ersig AL, Williams JK, Hadley DW, Koehly LM. Communication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: a pilot study. Genet Med. 2009 Oct;11(10):728-34. doi: 10.1097/GIM.0b013e3181b3f42d. PubMed 19707152 ↗
  • Desine S, Eskin L, Bonham VL, Koehly LM. Social support networks of adults with sickle cell disease. J Genet Couns. 2021 Oct;30(5):1418-1427. doi: 10.1002/jgc4.1410. Epub 2021 Apr 12. PubMed 33847032 ↗
09

Timeline

Tracking since Sep 25, 2026

Started Jul 2012 (actual).

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2012
First posted
Jul 4, 2012
StartActual
Jul 5, 2012
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01633021
Responsible party
Sponsor
First posted
Jul 4, 2012
Start date
Jul 5, 2012
Last update
Oct 29, 2026

Study contacts

Laura M Koehly, Ph.D.
principal investigator · National Human Genome Research Institute (NHGRI)

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion